Current Portfolio

Electra Therapeutics

Late clinical-stage biotech developing FIC SIRP-targeted antibodies for immune disorders and cancer.

Responsible partner
News

Key Facts

Sector: Life Sciences
Country: United States
Fund: LSP 7
Entry: 2025
Website: Electra Therapeutics

Electra Therapeutics

Responsible Partner

Christoph Broja

Christoph Broja

Partner

Do You Want to Know More?

We are eager to explore how we can achieve great things together.